Company intelligence / Profile preview
Jiangzhong Pharmaceutical
Nanchang, Jiangxi, Chinacrjz.com ↗
- Ownership
- Private
- Employees
- ~4182
- Development stage
- Other
01
Overview
Jiangzhong Pharmaceutical has several approved drugs on the market, including both traditional Chinese medicines and small molecule pharmaceuticals. Its portfolio includes treatments for pharyngitis, anesthesia, common cold, and inflammatory bowel diseases. The company also develops health foods and functional foods. Some programs are in preclinical or Phase 2 stages; most key assets are already commercialized in China.
- Therapeutic areas
- OtherGastroenterologyInfectious Diseases
- Modalities
- Herbal medicineSmall molecule drugProbiotics
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Synergy with Haisi Pharmaceutical after acquisition by parent company
Beyond the preview
Go deeper on Jiangzhong Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangzhong Pharmaceutical.